Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

SELLAS Life Sciences (SLS) EBT Margin (2020 - 2022)

Historic EBT Margin for SELLAS Life Sciences (SLS) over the last 4 years, with Q1 2022 value amounting to 1673.5%.

  • SELLAS Life Sciences' EBT Margin fell 16341100.0% to 1673.5% in Q1 2022 from the same period last year, while for Dec 2022 it was 4195.0%, marking a year-over-year decrease of 38621800.0%. This contributed to the annual value of 4130.1% for FY2022, which is 38546300.0% down from last year.
  • Latest data reveals that SELLAS Life Sciences reported EBT Margin of 1673.5% as of Q1 2022, which was down 16341100.0% from 234.37% recorded in Q2 2021.
  • In the past 5 years, SELLAS Life Sciences' EBT Margin ranged from a high of 39.39% in Q1 2021 and a low of 1673.5% during Q1 2022
  • For the 3-year period, SELLAS Life Sciences' EBT Margin averaged around 541.54%, with its median value being 226.63% (2021).
  • Within the past 5 years, the most significant YoY rise in SELLAS Life Sciences' EBT Margin was -16341100bps (2022), while the steepest drop was -16341100bps (2022).
  • Over the past 3 years, SELLAS Life Sciences' EBT Margin (Quarter) stood at 218.89% in 2020, then dropped by -7bps to 234.37% in 2021, then crashed by -614bps to 1673.5% in 2022.
  • Its EBT Margin was 1673.5% in Q1 2022, compared to 234.37% in Q2 2021 and 39.39% in Q1 2021.